Thomas Malley

Thomas R.
Malley is currently Chairman at Project C.U.R.E., Inc., Independent Director at Kura Oncology, Inc. since 2015, Director at Benevolent Healthcare Foundation, Independent Director at Kiniksa Pharmaceuticals Ltd. and Kiniksa Pharmaceuticals Corp.
since 2016, Independent Director at Kiniksa Pharmaceuticals International Plc since 2024, and President at Mossrock Capital LLC since 2007.
Former positions include Director at Cougar Biotechnology, Inc. from 2007 to 2009, Director at Innovative Acquisitions Corp., Board of Director at Craig Hospital from 2007 to 2013, Director at Janssen Oncology, Inc. from 2007 to 2009, Independent Director at Puma Biotechnology, Inc. from 2011 to 2015, Independent Director at OvaScience, Inc. from 2012 to 2017, Independent Director at Synageva BioPharma Corp.
from 2012 to 2015, Independent Non-Executive Director at BeOne Medicines Ltd. from 2016 to 2024, Executive Vice President at Janus Henderson Investors US LLC from 1991 to 2008, and Portfolio Manager at Janus Henderson Global Life Sciences Fund from 1999 to 2007.
Education includes an undergraduate degree from Stanford University conferred in 1991.